Diastolic calcium is elevated in metabolic recovery of cardiomyocytes expressing elevated levels of the Na+/H+ exchanger

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 12, 2008, Pages 850-859

  Baczkó, István ^a,b   Mraiche, Fatima ^a   Light, Peter E ^a   Fliegel, Larry ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Ca2+ transient; Contractile function; Heart failure; Metabolic inhibition; Metabolic recovery; Na+ H+ exchanger

Indexed keywords

CALCIUM; SODIUM; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIASTOLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; METABOLIC INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SODIUM CELL LEVEL; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; CATION TRANSPORT PROTEINS; DIASTOLE; GUANIDINES; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; SODIUM-HYDROGEN ANTIPORTER; STRESS, PHYSIOLOGICAL; SULFONES;

EID: 57349181248     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-092     Document Type: Article

References (35)

1. + exchange inhibitors: potential mechanisms of action. Basic Res. Cardiol. 96: 306-311. doi:10.1007/s003950170037. PMID:11518185.
2. Ayoub, I.M., Kolarova, J., Yi, Z., Trevedi, A., Deshmukh, H., Lubell, D.L., et al. 2003. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation, 107(13): 1804-1809. doi:10.1161/01.CIR.0000058704.45646.0D. PMID:12665493.
3. 2+ overload during hypoxia-reoxygenation in rat ventricular myocytes. J. Physiol. 550(Pt 3): 889-898. doi:10.1113/jphysiol.2003.043372. PMID:12807988.
4. ATP channel-mediated cardioprotection involves posthypoxic reductions in calcium overload and contractile dysfunction: mechanistic insights into cardioplegia. FASEB J. 19(8): 980-982. doi:10.1096/fj.04-3008fje. PMID:15774423.
5. Cook, A.R., Bardswell, S.C., Pretheshan, S., Dighe, K., Kanaganayagam, G.S., Jabr, R.I., et al. 2008. Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? J. Mol. Cell. Cardiol. doi:10.1016/j.yjmcc.2008.10.013. In press.
6. Cox, C.S., Jr., Sauer, H., Allen, S.J., Buja, L.M., and Laine, G.A. 2002. Sodium/hydrogen-exchanger inhibition during cardioplegic arrest and cardiopulmonary bypass: an experimental study. J. Thorac. Cardiovasc. Surg. 123(5): 959-966. doi:10.1067/mtc.2002.120715. PMID:12019382.
7. Dyck, J.R.B., Maddaford, T., Pierce, G.N., and Fliegel, L. 1995. Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc. Res. 29: 203-208. PMID:7736496.
8. Eisner, D.A., Nichols, C.G., O'Neill, S.C., Smith, G.L., and Valdeolmillos, M. 1989. The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J. Physiol. 411: 393-418. PMID:2614727.
9. 2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells. Jpn. Heart J. 39(1): 1-44. PMID:9601480.
10. + exchanger isoform 1. Int. J. Biochem. Cell Biol. 37(1): 33-37. doi:10.1016/j.biocel.2004.02. 006. PMID:15381146.
11. + exchange isoform 1 mRNA expression in isolated rat hearts. Am. J. Physiol. 277: H993-H998. PMID:10484421.
12. Hayashi, H. 2000. Pathogenesis and the role of Ca2+ overload during myocardial ischemia/reperfusion. Nagoya J. Med. Sci. 63(3-4): 91-98. PMID:11201989.
13. 2+ concentration and pHi during metabolic inhibition. Am. J. Physiol. 262(3 Pt 1): C628-C634. PMID:1550207.
14. + exchanger and ischemia-reperfusion injury in the myocardium. Am. J. Physiol. Heart Circ. Physiol. 292(5): H2237-H2247. doi:10.1152/ajpheart.00855.2006. PMID:17209001.
15. Jeffrey, F.M.H., Mallow, C.R., and Radda, G.K. 1987. Influence of intracellular acidosis on contractile function in the working rat heart. Am. J. Physiol. 253: H1499-H1505. PMID:3425750.
16. Karmazyn, M. 2001. Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target. Basic Res. Cardiol. 96(4): 325-328. doi:10.1007/s003950170040. PMID:11518188.
17. + exchanger, from molecular to its role in disease. Edited by M. Karmazyn, M. Avkiran, and L. Fliegel. Kluwer Academic Publishers, Boston.
18. + exchange: structure, regulation, and its role in heart disease. Circ. Res. 85: 777-786. PMID:10532945.
19. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs, 61(3): 375-389. doi:10.2165/ 00003495-200161030-00006. PMID:11293648.
20. + exchanger: a target for cardiac therapeutic intervention. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5(4): 323-335. doi:10.2174/1568006054553417. PMID:16101565.
21. Katz, A.M., and Hecht, H.H. 1969. The early "pump" failure of the ischemic heart. Am. J. Med. 47: 497-502. doi:10.1016/0002-9343(69) 90180-6. PMID:4241836.
22. Knight, D.R., Smith, A.H., Flynn, D.M., MacAndrew, J.T., Ellery, S.S., Kong, J.X., et al. 2001. A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J. Pharmacol. Exp. Ther. 297: 254-259. PMID:11259552.
23. + antiporter mRNA levels in response to respiratory and metabolic acidosis. J. Clin. Invest. 87(2): 747-751. doi:10.1172/JCI115057. PMID:1846882.
24. Lazdunski, M., Frelin, C., and Vigne, P. 1985. The sodium/ hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J. Mol. Cell. Cardiol. 17: 1029-1042. doi:10.1016/S0022-2828(85)80119-X. PMID:3001319.
25. Li, Q., Hohl, C.M., Altschuld, R.A., and Stokes, B.T. 1989. Energy depletion-repletion and calcium transients in single cardiomyocytes. Am. J. Physiol. 257(3 Pt 1): C427-C434. PMID:2782386.
26. + exchanger. Can. J. Physiol. Pharmacol. 84(11): 1081-1095. doi:10.1139/Y06-065. PMID:17218973.
27. Moens, A.L., Claeys, M.J., Timmermans, J.P., and Vrints, C.J. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 100(2): 179-190. doi:10.1016/j.ijcard.2004.04.013. PMID:15823623.
28. + exchanger. Eur. J. Biochem. 268(17): 4674-4685. doi:10.1046/j.1432-1327. 2001.02391.x. PMID:11532004.
29. + exchange inhibitor, attenuates reperfusion-induced arrhythmias in isolated perfused rat heart. J. Anesth. 18(3): 196-202. doi:10.1007/s00540-004-0232-x. PMID:15290419.
30. + exchanger. J. Biol. Chem. 280(18): 17863-17872. doi:10.1074/jbc.M409608200. PMID:15677483.
31. 2+ exchanger in ouabain-induced inotropy and arrhythmogenesis in guineapig myocardium as revealed by SEA0400. J. Pharmacol. Sci. 103(2): 241-246. doi:10.1254/jphs.FP0060911. PMID:17310075.
32. van Borren, M.M., Baartscheer, A., Wilders, R., and Ravesloot, J.H. 2004. NHE-1 and NBC during pseudo-ischemia/reperfusion in rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 37(2): 567-577. doi:10.1016/j.yjmcc. 2004.05.017. PMID:15276026.
33. + exchanger are resistant to cardiac ischemia-reperfusion injury. Circ. Res. 93(8): 776-782. doi:10.1161/01.RES.0000094746.24774.DC. PMID:12970112.
34. 2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. Eur. J. Pharmacol. 572(1): 1-11. doi:10.1016/j.ejphar.2007.05.065. PMID:17822695.
35. + exchanger activity and expression in human ventricular myocardium. J. Am. Coll. Cardiol. 36(2): 534-540. doi:10.1016/S0735-1097(00)00730-0. PMID:10933369.